Congenital Hyperinsulinism - 18 Studies Found

Completed : A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism
: Congenital Hyperinsulinism
: 2015-10-26
:
  • Drug: Cohort 1 XOMA 358 single
Recruiting : Fluorodopa F 18 in Congenital Hyperinsulinism
: Congenital Hyperinsulinism
: 2013-12-20
: Drug: Fluorodopa F 18 A dose of Fluorodopa F 18, 3-6 MBq/Kg (0.08-0.16 mCi/kg), will be injected intrave
Recruiting : Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy
: Congenital Hyperinsulinism
: 2010-02-17
: Drug: Lanreotide autogel The dose of Lan-ATG will be calculated according to the surface area of the pat
Completed : Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism
: Congenital Hyperinsulinism
: 2007-12-10
:
  • Drug: Exendin-(9-39) A short t
Completed : Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism
: Non-focal Congenital Hyperinsulinism
: 2014-03-28
: Procedure: restrictive pancreatic resection Restrictive, spleen-preserving resection of the pancreatic t
Recruiting : CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism
: Congenital Hyperinsulinism
: 2016-10-14
:
  • Drug: Glucagon Room-temperatur
Completed : Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity
: Congenital Hyperinsulinism
: 2009-05-08
:
  • Drug: Exendin-(9-39) 100-500pm
Recruiting : Effect of Exendin-(9-39) On Glucose Requirements To Maintain Euglycemia
: Congenital Hyperinsulinism
: 2009-02-02
:
  • Drug: exendin-(9-39) exendin-(
Completed : Sandostatine® LP and Hyperinsulinism
: Congenital Hyperinsulinism
: 2009-09-29
: Drug: Sandostatine LP Intramuscular injection of Sandostatine LP, once per month Dosage : 10 mg, 20 mg,
Available : Compassionate Use of SOM230 for Hyperinsulinemic/Hypoglycemia
: Congenital Hyperinsulinism
: 2016-07-13
: Drug: Pasireotide Other Names:
  • Signifor
  • SOM230
Next >>>